Maharashtra News Flash
Buisness

The Q4 PAT reported by Torrent Pharma was 287 crore rupees

On the strength of strong sales across regions, Torrent Pharma on Tuesday declared a consolidated profit after tax of Rs 287 crore for the fourth quarter ended March 2023.

In the January-March quarter of the 2021–22 fiscal year, the medicine manufacturer had recorded a net loss of Rs 118 crore.

According to a statement from Torrent Pharma, the company's sales increased to Rs 2,491 crore for the fourth quarter from Rs 2,131 crore in the same quarter last year.

The medicine manufacturer reported a profit after tax of Rs 1,245 crore for the year that ended March 2023 as opposed to Rs 777 crore in FY22.

Last fiscal year, the income increased to Rs 9,620 crore from Rs 8,508 crore.

According to the business, the board of directors advised the shareholders to approve the issuing of shares, convertible bonds, and debentures via qualified institutional placement (QIP), depository receipts, or any other means for a sum not to exceed Rs 5,000 crore.

A final dividend of Rs 8 per share of Rs 5 was also authorised by the board.

On the BSE, shares of the pharmaceutical company finished 0.69 percent higher at Rs 1,717.15.

Related posts

Check the most recent information on Musk’s microblogging app before joining communities, and improve the X video experience on Android

India lowers the 10% import charge on parts for mobile phones

After the Hindenburg report, a committee established by the SC claims that Adani Group's retail exposure expanded

Admin

Should You Buy After HCL Tech Jumps 4% After Deal Wins At All-Time High in Q2?

Elon Musk, the former CEO of Twitter, resigns from his position and remains as CTO

Admin

The $5 trillion Indian economy will grow to become the third largest in three years. FinMin Report